India has cancelled the import licence granted to a Chinese pharma company after it refused to allow an Indian team to inspect the facility, Health Minister Ghulam Nabi Azad said Tuesday.

Azad said Chongqing Daxin Pharmaceutical Limited in Chongqing in China refused the visiting Indian inspecting team of the Central Drugs Standard Control Organisation (CDSCO) officials to inspect their facility.

According to Azad, the company said they have stopped manufacturing some of the registered drugs and are not in a position to export other drugs to India. 'The registration certificate and import licenses granted in favour of the firm were, therefore, cancelled in June 2011,' he told the Rajya Sabha.

The CDSCO lays down standards of drugs, cosmetics, diagnostics and devices in the country and also regulates market authorization of new drugs, approves drug formulations for manufacture and regulates clinical research in India.

Source: IANS